Vitro, S.A.B. de C.V.
VITOF
$0.15
-$0.51-77.27%
OTC PK
| 06/30/2025 | 12/31/2024 | 09/30/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -0.60% | -10.42% | -10.95% | -10.95% | -88.78% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.60% | -10.42% | -10.95% | -10.95% | -88.78% |
| Cost of Revenue | -2.31% | 1.28% | 2.97% | 2.97% | -90.91% |
| Gross Profit | 1.98% | -24.07% | -25.18% | -25.18% | -82.63% |
| SG&A Expenses | -6.29% | 31.42% | -16.54% | -16.54% | -78.50% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -96.39% | -158.24% | -136.02% | -136.02% | 255.93% |
| Total Operating Expenses | -7.23% | 10.87% | -10.97% | -10.97% | -87.92% |
| Operating Income | 11,275.61% | -355.52% | -10.74% | -10.74% | -99.91% |
| Income Before Tax | 180.87% | -220.83% | -1,242.83% | -1,242.83% | -291.81% |
| Income Tax Expenses | 100.31% | -93.89% | -77.00% | -77.00% | -1,559.95% |
| Earnings from Continuing Operations | 201.82% | -286.21% | -1,818.60% | -1,818.60% | -248.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 201.82% | -182.51% | -340.13% | -340.13% | -248.11% |
| EBIT | 11,275.61% | -355.52% | -10.74% | -10.74% | -99.91% |
| EBITDA | 121.35% | -281.90% | -78.43% | -78.43% | -95.25% |
| EPS Basic | 209.09% | -177.26% | -333.33% | -333.33% | -237.50% |
| Normalized Basic EPS | 186.72% | -265.49% | -1,244.12% | -1,244.12% | -276.73% |
| EPS Diluted | 209.09% | -174.68% | -333.33% | -333.33% | -237.50% |
| Normalized Diluted EPS | 186.72% | -265.49% | -1,244.12% | -1,244.12% | -276.73% |
| Average Basic Shares Outstanding | -6.66% | 6.76% | 2.91% | 2.91% | 7.71% |
| Average Diluted Shares Outstanding | -6.66% | 6.76% | 2.91% | 2.91% | 7.71% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |